# Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis

> **NCT06016517** · — · NOT_YET_RECRUITING · sponsor: **Tufts Medical Center** · enrollment: 18 (estimated)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** Etanercept
- **DRUG:** Adalimumab
- **DRUG:** Upadacitinib
- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT06016517
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-01
- **Primary completion:** 2027-12-15
- **Final completion:** 2028-12-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06016517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06016517, "Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06016517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*